(3R)-3-AMINO-4-(3,4-DIFLUOROPHENYL)-1-(5,6-DIHYDRO-3-(TRIFLUOROMETHYL)-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)-1-BUTANONE
UNII QHD8RD5DCQ
Substance Identification & Data
This profile provides standardized clinical and technical data for (3r)-3-amino-4-(3,4-difluorophenyl)-1-(5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo(4,3-a)pyrazin-7(8h)-yl)-1-butanone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QHD8RD5DCQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 486459-88-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H16F5N5O VZQYRRVZSLWCAA-SNVBAGLBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3r)-3-amino-4-(3,4-difluorophenyl)-1-(5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo(4,3-a)pyrazin-7(8h)-yl)-1-butanone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.